Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Klinge continues to focus on cytostatic/immunosuppressive carboxamides

July 21, 1999

AltaRex proposes increase in enrollment in OvaRex MAb trial

July 15, 1999

Zadaxin triple therapy shows promising results in preclinical model of colorectal cancer

July 14, 1999

Therion Biologics completes financing, accelerates therapeutic vaccine programs

July 9, 1999

Cell Genesys completes phase I/II GVAX trial and earns milestone payment

July 6, 1999

IL-4 fusion toxin effective in preclinical Kaposi's sarcoma models

July 2, 1999

Avax to launch M-Vax in Australia, forms joint venture for AC Vaccine

July 2, 1999

Transgene initiates phase I trial of malignant melanoma product

June 25, 1999

ImmunoGen receives second milestone payment for anticancer prodrug from SmithKline Beecham

June 22, 1999

Corixa teams up with Japan Tobacco on lung cancer vaccine research

June 21, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...